Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 193(8): 3947-58, 2014 Oct 15.
Article in English | MEDLINE | ID: mdl-25210119

ABSTRACT

Biologic drugs, including enzyme-replacement therapies, can elicit anti-drug Abs (ADA) that may interfere with drug efficacy and impact patient safety. In an effort to control ADA, we focused on identifying regimens of immune tolerance induction that may be readily available for clinical use. Data generated in both wild-type mice and a Pompe disease mouse model demonstrate that single-cycle, low-dose methotrexate can be as effective as three cycles of methotrexate in providing a long-lived reduction in alglucosidase alfa-specific ADA. In addition, we show that methotrexate induces Ag-specific tolerance as mice generate similar Ab responses to an irrelevant Ag regardless of prior methotrexate treatment. Methotrexate-induced immune tolerance does not seem to involve cell depletion, but rather a specific expansion of IL-10- and TGF-ß-secreting B cells that express Foxp3, suggesting an induction of regulatory B cells. The mechanism of immune tolerance induction appears to be IL-10 dependent, as methotrexate does not induce immune tolerance in IL-10 knockout mice. Splenic B cells from animals that have been tolerized to alglucosidase alfa with methotrexate can transfer tolerance to naive hosts. We hypothesize that methotrexate induction treatment concomitant with initial exposure to the biotherapeutic can induce Ag-specific immune tolerance in mice through a mechanism that appears to involve the induction of regulatory B cells.


Subject(s)
B-Lymphocytes, Regulatory/immunology , Folic Acid Antagonists/pharmacology , Immune Tolerance/drug effects , Methotrexate/pharmacology , alpha-Glucosidases/immunology , Adoptive Transfer , Animals , Antigens, CD1d/immunology , Antimetabolites, Antineoplastic/pharmacology , B-Lymphocytes, Regulatory/drug effects , B-Lymphocytes, Regulatory/transplantation , CD5 Antigens/immunology , CD8-Positive T-Lymphocytes/immunology , Forkhead Transcription Factors/biosynthesis , Immunoglobulin G/blood , Immunoglobulin G/immunology , Interleukin-10/genetics , Interleukin-10/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , T-Lymphocytes, Regulatory/immunology , Transforming Growth Factor beta/metabolism
2.
J Immunol ; 189(2): 732-43, 2012 Jul 15.
Article in English | MEDLINE | ID: mdl-22711884

ABSTRACT

Rabbit anti-thymocyte globulin (Thymoglobulin) effectively treats transplant rejection but induces anti-rabbit Ab responses, which limits routine readministration. Aiming to tolerize anti-rabbit responses, we coadministered a brief methotrexate regimen with a murine version of Thymoglobulin (mATG) for effects on anti-mATG Abs and cardiac allotransplantation in mice. Although both single and three courses of methotrexate could significantly inhibit anti-drug Ab titers to repeated mATG treatment, surprisingly, the single course given at the first mATG administration was most effective (>99% reduction). The transient methotrexate treatment also significantly improved pharmacokinetics and pharmacodynamics of repeated mATG administration. In the cardiac allograft model, the combination of transient mATG and methotrexate given only at the time of transplant dramatically improved allograft survival (>100 d) over either agent alone (<30 d). Anti-drug Ab titers were reduced and mATG exposure was increased which resulted in prolonged rather than enhanced mATG-mediated effects when combined with methotrexate. Moreover, methotrexate administration significantly reduced alloantibodies, suggesting that methotrexate not only decreases anti-drug Ab responses but also reduces Ab responses to multiple tissue-derived alloantigens simultaneously. These data suggest that mATG and methotrexate together can provide long-term allograft survival potentially through the induction of immune tolerance.


Subject(s)
Antilymphocyte Serum/administration & dosage , Graft Survival/immunology , Heart Transplantation/immunology , Immune Tolerance/drug effects , Immunosuppressive Agents/administration & dosage , Methotrexate/administration & dosage , Animals , Dose-Response Relationship, Immunologic , Drug Therapy, Combination , Graft Survival/drug effects , Heart Transplantation/pathology , Immune Tolerance/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Species Specificity , Transplantation, Homologous
3.
J Neurosci Methods ; 117(2): 111-21, 2002 Jun 30.
Article in English | MEDLINE | ID: mdl-12100976

ABSTRACT

Epidermal growth factor (EGF) responsive neural progenitors are defined by clonal growth from single cells. In previous studies we were unable to obtain clones at single cell densities using trypsinized cells and trituration alone always gave cellular aggregates. Here we report on single cell derived clones using a technique involving trituration of EGF responsive neurospheres, cell filtration, and single cell sorting using a MoFlo high speed fluorescence activated cell sorter. Single cell deposition was confirmed by labeling cells with Hoechst 33342 and Flow-check Fluorospheres, and visualization by fluorescence microscopy. The cells were deposited into liquid medium and grown from single cells in 10-20 ng/ml EGF for 12-14 days. This gave a cloning efficiency of 2.12%+/-0.37. New colonies occurred as late as day 18 post-sort. Tritiated thymidine suicide indicates that a percentage of these cells are cycling. Immunohistochemical analysis for oligodendrocytes, astroglia, and neuronal lineages performed on colonies at 10-14 and 21-28 days gave 39% uni-lineage, 36% bi-lineage, and 25% tri-lineage colonies. A total of five different types of progenitor cells were observed. In individual colonies, oligodendrons predominated with a lesser presence of astroglial or neuronal cell types. This approach establishes a reliable and reproducible method for single cell cloning of neurosphere cells.


Subject(s)
Cell Separation/methods , Epidermal Growth Factor/pharmacology , Neurons/cytology , Stem Cells/cytology , Animals , Antimetabolites , Biomarkers , Bromodeoxyuridine , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Lineage , Cell Separation/instrumentation , Clone Cells , Immunohistochemistry , Mice , Mice, Inbred BALB C , Neurons/drug effects , Stem Cells/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...